ChemicalBook >> CAS DataBase List >>CYM 2503
CYM 2503
- CAS No.
- 1308833-36-4
- Chemical Name:
- CYM 2503
- Synonyms
- CYM 2503;Neuropeptide Y Receptor,electrographic seizure,NPY receptor,CYM 2503,seizure,inhibit,CYM2503,Inhibitor,epilepsy,GalR2,CYM-2503;L-Lysinamide, 3-cyclohexyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanyl-N-(1,2-dihydro-4-methyl-2-oxo-7-quinolinyl)-N6-[(1,1-dimethylethoxy)carbonyl]-;tert-butyl N-[(5S)-5-[(2S)-3-cyclohexyl-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]-5-[(4-methyl-2-oxo-1,2-dihydroquinolin-7-yl)carbamoyl]pentyl]carbamate;(9H-FLUOREN-9-YL)METHYL((S)-1(((S)-6(TERTBUTOXYCARBONYL) AMINO-1-((4-METHYL-2-OXO-1,2-DIHYDROQUINOLIN-7-YL)AMINO)-1-OXOHEXAN-2-YL)AMINO))-3-CYCLOHEXYL-1-OXOPROPAN-2-YL) CARBAMATE;tert-butyl ((S)-1-(((S)-6-((tert-butoxycarbonyl) amino)-1-((4-methyl-2-oxo-1,2-dihydroquinolin-7-yl) amino)-1-oxohexan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl) carbamate fluorene-9-methyl ester
- CBNumber:
- CB73369729
- Molecular Formula:
- C45H55N5O7
- Molecular Weight:
- 777.95
- MDL Number:
- MFCD31618422
- MOL File:
- 1308833-36-4.mol
- MSDS File:
- SDS
- TDS File:
- TDS
Last updated:2026-05-28 05:17:44
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319 |
| Precautionary statements | P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330 |
CYM 2503 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 36590 | CYM 2503 ≥95% | 1308833-36-4 | 1mg | $40 | 2026-04-30 | Buy |
| Cayman Chemical | 36590 | CYM 2503 ≥95% | 1308833-36-4 | 5mg | $158 | 2026-04-30 | Buy |
| Cayman Chemical | 36590 | CYM 2503 ≥95% | 1308833-36-4 | 10mg | $275 | 2026-04-30 | Buy |
| Cayman Chemical | 36590 | CYM 2503 ≥95% | 1308833-36-4 | 25mg | $590 | 2026-04-30 | Buy |
| ChemScene | CS-0084177 | CYM2503 96.01% | 1308833-36-4 | 5mg | $146 | 2026-06-04 | Buy |
CYM 2503 Chemical Properties, Uses, Production
Uses
CYM2503 is a putative GalR2-positive allosteric modulator. CYM2503 increases the latency to first electrographic seizure and decreases the total time in seizure. CYM2503 also attenuates electroshock-induced seizures in mice. Galanin receptors type 1 (GalR1) and/or type 2 (GalR2) represent unique pharmacological targets for the research of seizures and epilepsy[1].
References
[1] Lu X, et al. GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proc Natl Acad Sci U S A. 2010;107(34):15229-15234. DOI:10.1073/pnas.1008986107
CYM 2503 Preparation Products And Raw materials
Raw materials
Preparation Products
CYM 2503 Suppliers
Global Suppliers ( 40)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696，15000506266 15000506266 | China | 4866 | 55 | |
| Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9799 | 58 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| Jinan Yaoyan Pharmaceutical Co., Ltd. | jnyaoyan@163.com | China | 3057 | 58 | |
| Nanjing Meihao Pharmaceutical Technology Co., Ltd. | meitaochem@126.com | meitaochem@126.com | China | 19087 | 58 |
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19852 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Changzhou Chenhong Biotechnology Co., Ltd. | +86-0519-85788828 +86-13775037613 | sales@chemrenpharm.com | China | 4083 | 58 |
| Suzhou youruike Chemical Pharmaceutical Technology Co., Ltd | 15317229551 | 15151849396@163.com | China | 975 | 58 |
| ShangHai ChuanQian Chemcial Technique Centre | 15869524721 | 3525679403@qq.com | China | 4566 | 58 |
1308833-36-4 (CYM 2503) Related Search:
(9H-FLUOREN-9-YL)METHYL((S)-1(((S)-6(TERTBUTOXYCARBONYL) AMINO-1-((4-METHYL-2-OXO-1,2-DIHYDROQUINOLIN-7-YL)AMINO)-1-OXOHEXAN-2-YL)AMINO))-3-CYCLOHEXYL-1-OXOPROPAN-2-YL) CARBAMATE
CYM 2503
L-Lysinamide, 3-cyclohexyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanyl-N-(1,2-dihydro-4-methyl-2-oxo-7-quinolinyl)-N6-[(1,1-dimethylethoxy)carbonyl]-
Neuropeptide Y Receptor,electrographic seizure,NPY receptor,CYM 2503,seizure,inhibit,CYM2503,Inhibitor,epilepsy,GalR2,CYM-2503
tert-butyl N-[(5S)-5-[(2S)-3-cyclohexyl-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]-5-[(4-methyl-2-oxo-1,2-dihydroquinolin-7-yl)carbamoyl]pentyl]carbamate
tert-butyl ((S)-1-(((S)-6-((tert-butoxycarbonyl) amino)-1-((4-methyl-2-oxo-1,2-dihydroquinolin-7-yl) amino)-1-oxohexan-2-yl) amino)-3-cyclohexyl-1-oxopropan-2-yl) carbamate fluorene-9-methyl ester
1308833-36-4
C45H55N5O7
